Treace To Release Q1 2026 Financial Results On May 8
24 Apr 2026 //
GLOBENEWSWIRE
Treace Medical Reports Q4 and Full-Year 2025 Financial Results
27 Feb 2026 //
GLOBENEWSWIRE
Treace Reschedules 2025 Financial Results Release To Feb 27, 2026
12 Feb 2026 //
GLOBENEWSWIRE
Treace Reports Preliminary 2025 Revenue Figures
13 Jan 2026 //
GLOBENEWSWIRE
Treace To Present At J.P. Morgan Healthcare Conference
30 Dec 2025 //
GLOBENEWSWIRE
Treace To Participate In Two Upcoming Investor Conferences
07 Nov 2025 //
GLOBENEWSWIRE
Treace Medical Concepts Reveals Q3 2025 Financial Performance
06 Nov 2025 //
GLOBENEWSWIRE
Treace To Release Q3 2025 Financial Results On Nov 6, 2025
23 Oct 2025 //
GLOBENEWSWIRE
Treace Medical to Highlight New Products at Investor Day
07 Aug 2025 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Strong Q2 2025 Financial Result
07 Aug 2025 //
GLOBENEWSWIRE
Treace`s Q2 2025 Financial Results to be Reported on August 7
24 Jul 2025 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Q1 2025 Financial Results
08 May 2025 //
GLOBENEWSWIRE
Treace to Report Q1 2025 Financial Results on May 8, 2025
24 Apr 2025 //
GLOBENEWSWIRE
Treace Showcases Innovations at 2025 ACFAS Conference
25 Mar 2025 //
GLOBENEWSWIRE
Treace to Report Q4 & Full-Year 2024 Financial Results on Feb 27
06 Feb 2025 //
GLOBENEWSWIRE
Treace Conducts First Surgeries With SpeedAkin Compression Implant
30 Jan 2025 //
GLOBENEWSWIRE
Treace Announces Preliminary, Unaudited Q4 & Full-Year 2024
13 Jan 2025 //
GLOBENEWSWIRE
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
02 Jan 2025 //
GLOBENEWSWIRE
Treace Announces First Surgical Cases with SpeedPlate Implant
16 Dec 2024 //
GLOBENEWSWIRE
Treace Appoints Guy Guglielmino as Chief Commercial Officer
02 Dec 2024 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Q3 2024 Financial Results
05 Nov 2024 //
GLOBENEWSWIRE
Treace to Participate in UBS Global Healthcare Conference
04 Nov 2024 //
GLOBENEWSWIRE
Treace To Report Q3 2024 Financial Results On Nov 5
22 Oct 2024 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
06 Aug 2024 //
GLOBENEWSWIRE
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
18 Jul 2024 //
GLOBENEWSWIRE
Treace to Present at Truist Securities MedTech Conference
28 May 2024 //
GLOBENEWSWIRE
Treace Medical Concepts Reports First Quarter 2024 Financial Results
06 May 2024 //
GLOBENEWSWIRE
Treace to Present at Bank of America Health Care Conference
17 Apr 2024 //
GLOBENEWSWIRE
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
25 Mar 2024 //
GLOBENEWSWIRE
Treace Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 2024 //
GLOBENEWSWIRE
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
07 Feb 2024 //
GLOBENEWSWIRE
Treace Announces Interim 3-Year ALIGN3D Clinical Study Data
02 Feb 2024 //
GLOBENEWSWIRE
Treace to Highlight Latest Product Innovations and ALIGN3D Study Outcomes
01 Feb 2024 //
GLOBENEWSWIRE
Treace Announces Preliminary, Unaudited Fourth Quarter & Full-Year 2023 Revenue
08 Jan 2024 //
GLOBENEWSWIRE
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 Dec 2023 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Treace to Present at Stifel 2023 Healthcare Conference
30 Oct 2023 //
GLOBENEWSWIRE
Treace to Report Third Quarter 2023 Financial Results
16 Oct 2023 //
GLOBENEWSWIRE
Treace Highlights Product Innovations and Updated ALIGN3D Clinical Study Data
20 Sep 2023 //
GLOBENEWSWIRE
Treace Medical Announces Patent Covering Bunion Correction Procedures
14 Sep 2023 //
GLOBENEWSWIRE
Treace Medical Announces Limited Market Release of Complementary Technologies
11 Sep 2023 //
GLOBENEWSWIRE
Treace Announces Participation in the 21st Annual Global Healthcare Conference
22 Aug 2023 //
GLOBENEWSWIRE
Treace Medical Appoints Nathan Minnich as Senior Vice President, Marketing
21 Aug 2023 //
GLOBENEWSWIRE
Treace Medical Concepts Reports Second Quarter 2023 Financial Results
08 Aug 2023 //
GLOBENEWSWIRE
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
18 Jul 2023 //
GLOBENEWSWIRE
Treace Appoints Julie Dewey as Chief Communications & Investor Relations Officer
12 Jul 2023 //
GLOBENEWSWIRE
Treace Medical Reports on Clinical Cases Using PSI with Lapiplasty System
13 Jun 2023 //
GLOBENEWSWIRE
Treace Concepts to Acquire Technology Enabling Patient Specific Instrumentation
01 Jun 2023 //
GLOBENEWSWIRE
Treace Medical Concepts Reports First Quarter 2023 Financial Results
08 May 2023 //
GLOBENEWSWIRE
Treace Announces Participation in the Bank of America 2023 Healthcare Conference
26 Apr 2023 //
GLOBENEWSWIRE
Treace to Report First Quarter 2023 Financial Results on May 8, 2023
20 Apr 2023 //
GLOBENEWSWIRE
Treace Medical Expands Market Leading Global IP Portfolio
19 Apr 2023 //
GLOBENEWSWIRE
Treace Publishes Inaugural ESG Report
04 Apr 2023 //
GLOBENEWSWIRE
Treace Concepts Reports Fourth Quarter and Full Year 2022 Financial Results
07 Mar 2023 //
GLOBENEWSWIRE
Treace Medical Announces Settlement of Lawsuit Against Fusion Orthopedics
03 Mar 2023 //
GLOBENEWSWIRE
Treace to Report Q4 and Full Year 2022 Financial Results on March 7, 2023
27 Feb 2023 //
GLOBENEWSWIRE
Treace Presents Updated ALIGN3D Data and Latest Product Innovations at ACFAS
09 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support